United States

Analyst Research

Report Title Price
Provider : S&P Capital IQ Quantitative Report
Provider : Stock Traders Daily
Provider : Pechala's Reports
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novavax Inc prices public offering of common stock

Thursday, 5 Jun 2014 08:55pm EDT 

Novavax Inc:Says that it has priced an underwritten public offering of 25 mln shares of common stock at a price to the public of $4.00 per share for gross proceeds of about $100 mln.Expects to receive net proceeds, after deducting the underwriting discount, of about $94 mln from the offering.Expects to grant to underwriters a 30-day option to purchase up to additional 3.75 mln shares of its common stock.Intends to use net proceeds from offering for general corporate purposes, advancement of its clinical-stage vaccine candidates and its pre-clinical research programs, manufacturing and process development activities, capital expenditures and other strategic purposes.Expects to close offering on or about June 11.Citigroup and JP Morgan are acting as joint book-running managers of offering.Piper Jaffray & Co. will act as Lead Manager and FBR and Ladenburg Thalmann & Co. Inc. as co-managers. 

Company Quote

-0.21 -3.85%
29 Apr 2016